Entrada Therapeutics, Inc. (TRDA)
10.62
+0.16
(+1.53%)
USD |
NASDAQ |
Jan 14, 16:00
10.62
0.00 (0.00%)
After-Hours: 20:00
Entrada Therapeutics Total Assets (Quarterly): 412.90M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | 218.07M |
| Janux Therapeutics, Inc. | 1.025B |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
| Theriva Biologics, Inc. | 30.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 72.18M |
| Shareholders Equity (Quarterly) | 340.72M |
| Debt to Equity Ratio | 0.1538 |
| Current Ratio | 14.08 |
| Net Debt Paydown Yield | 1.09% |